Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
株式のランク #96
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
株価
$38.41
時価総額
$170.67B
変化(1日)
1.17%
変化(1年)
-49.92%
DK
取引 Novo Nordisk A/S (NVO)

カテゴリー

Novo Nordisk A/S(NVO)のP/B比率
February 2026 時点のP/B比率 TTM: 7.11
Novo Nordisk A/S の最新の財務報告および株価によると、現在のP/B比率(TTM)は 7.11 です。2026 年末時点でのP/B比率は 0 でした。
Novo Nordisk A/S の P/B 比率の履歴(2026 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差
6.3842 -10.24%
US
2.4551 -65.48%
US
4.364 -38.64%
BE
2.5504 -64.14%
AU
5.9034 -17.00%
NL